Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Endothelial cells have functional deficits in progeria

Feb. 13, 2020

CVie Therapeutics and UNIMIB divulge compounds for heart failure

Feb. 12, 2020

AskBio doses first patient in phase I study of NAN-101

Feb. 5, 2020

Agmatine is decreased in sepsis and may be a clinical biomarker and therapeutic agent

Feb. 5, 2020

Long QT genes mostly short on evidence

Feb. 3, 2020

PULSAR trial of sotatercept in pulmonary arterial hypertension meets primary endpoint

Jan. 28, 2020

Retinoic X receptor as therapeutic target for poststroke recovery

Jan. 28, 2020

Novel panaxatriol derivative shows efficacy in rat model of MI/R injury

Jan. 27, 2020

Fat or fiber, cFAP activation is problematic for heart

Jan. 27, 2020

FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease

Jan. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...